{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:10:40Z","timestamp":1760055040500,"version":"build-2065373602"},"reference-count":19,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["M\u00e9decine et Maladies Infectieuses"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1016\/j.medmal.2005.02.001","type":"journal-article","created":{"date-parts":[[2005,2,26]],"date-time":"2005-02-26T19:44:46Z","timestamp":1109447086000},"page":"62-67","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["La tig\u00e9cycline, un nouvel antibiotique \u00e0 l'\u00e9tude chez l'homme"],"prefix":"10.1016","volume":"35","author":[{"given":"J.-P.","family":"Stahl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medmal.2005.02.001_bib1","article-title":"r\u00e9sultats 2002, place de la France","author":"Trystam","year":"2004","journal-title":"BEH"},{"issue":"4","key":"10.1016\/j.medmal.2005.02.001_bib2","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1574-695X.1997.tb01055.x","article-title":"Emergent antibiotic resistance: health risks and economic impact","volume":"18","author":"Cassell","year":"1997","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.medmal.2005.02.001_bib3","unstructured":"Cercenado E, Mar\u00edn M, Mar t\u00ednez-Alarc\u00f3n J, Bouza E, In vitro Activities of New Antimicrobials against Different Nocardia Species. Session #215, Control #2003, Presentation #E-2062."},{"key":"10.1016\/j.medmal.2005.02.001_bib4","unstructured":"Stevens T, Johnson B, Johnson J, Bouchillon S, Hoban D, Gaylord C, et al. Tigecycline Evaluation Surveillance Trial (T.E.S.T.) \u2013 In vitro Antibacterial Activity against Fastidious Isolates. Session #215, Control #3408, Presentation #E-2054."},{"key":"10.1016\/j.medmal.2005.02.001_bib5","unstructured":"Lopez O, Rodr\u00edguez-Avial C, Rodr\u00edguez-Avial I, Picazo JJ. In vitro activity of Tigecycline (GAR-936) and other Antimicrobials against Tetracycline and Cipro. oxacin-Resistant Campylobacter spp. Isolated from Humans in 2003. Session #215, Control #1301, Presentation #E-2055."},{"key":"10.1016\/j.medmal.2005.02.001_bib6","unstructured":"Rodr\u00edguez-Avial I, Rodr\u00edguez-Avial C, Culebras E, Betriu C, Picazo JJ. Comparison of the In vitro Activity of Tigecycline (GAR-936) with Tetracycline and Minocycline in Blood Culture Isolates of Viridans Group Streptococci (VGS). Session #215, Control #1283, Presentation #E-2056."},{"key":"10.1016\/j.medmal.2005.02.001_bib7","unstructured":"Stevens T, Johnson B, Johnson J, Bouchillon S, Hoban D, Gaylord C, et al. Tigecycline Evaluation Surveillance Trial (T.E.S.T.) \u2013In vitro Antibacterial Activity against Methicillin Resistant and Methicillin Sensitive Staphylococcus aureus Isolates. Session #215, Control #2200, Presentation #E-2061."},{"key":"10.1016\/j.medmal.2005.02.001_bib8","unstructured":"Huang V, Rybak MJ, Evaluation of Tigecycline (TG),Minocycline (MN), Tetracycline (TT), Teicoplanin (TP), and Vancomycin (VN) against Community-Associated (CA-MRSA) and Multidrug-Resistant (MDR-MRSA) Methicillin-Resistant Staphylococcus aureus. Session #215, Control #1526, Presentation #E-2063."},{"key":"10.1016\/j.medmal.2005.02.001_bib9","unstructured":"Fritsche TR, Kirby J, Jones R.N. Activity of Tigecycline Tested against 3,498 Staphylococcus aureus: An Assessment versus Community-Acquired ORSA. Session #212, Control #739, Presentation #C2-2000."},{"key":"10.1016\/j.medmal.2005.02.001_bib10","unstructured":"Betriu C, Gomez M, Rodr\u00edguez-Avial I, Culebras E, Picazo JJ, In vitro Activity of Tigecycline and Comparative Antimicrobial Agents against Ampicillin-Resistant Haemophilus influenzae Isolates. Session #215,Control #1543,Presentation #E-2064."},{"key":"10.1016\/j.medmal.2005.02.001_bib11","unstructured":"Stevens T, Johnson B, Johnson J, Bouchillon S, Hoban D, Gaylord C, et al. Tigecycline Evaluation Surveillance Trial (T.E.S.T.) \u2013In vitro Antibacterial Activity against Selected Species of Enterobacteriaceae. Session #215, Control #2668, Presentation #E-2060."},{"key":"10.1016\/j.medmal.2005.02.001_bib12","unstructured":"Stevens T, Johnson B, Johnson J, Bouchillon S, Hoban D, Gaylord C, et al. In Vitro Antibacterial Activity of Tigecycline against Isolates of Vancomycin-Resistant and -Sensitive Enterococcus faecium from the Tigecycline Evaluation Surveillance Trial (T.E.S.T.). Session #215, Control #2806, Presentation #E-2059."},{"key":"10.1016\/j.medmal.2005.02.001_bib13","unstructured":"Fritsche TR, Strabala P, Sader HS, Jones RN. Activity of Tigecycline Tested against Tetracycline-Resistant Enterobacteriaceae. Session #215, Control #857, Presentation #E-2058."},{"key":"10.1016\/j.medmal.2005.02.001_bib14","unstructured":"Betriu C, Culebras E, G\u00f3mez M, Rodr\u00edguez-Avial I, Picazo JJ, In vitro Activity of Tigecycline against Bacteroides Species. Session #215,Control #1071,Presentation #E-2057."},{"key":"10.1016\/j.medmal.2005.02.001_bib15","unstructured":"Ong CT, Babalola CP, Nightingale CH, Nicolau DP Penetration, Intracellular Accumulation, and Ef .ux of Tigecycline in Human Polymorphonuclear Neutrophils (PMNs). Session #135, Control #914, Presentation #A-1303."},{"key":"10.1016\/j.medmal.2005.02.001_bib16","unstructured":"Owen JS, Darling IM, Troy SM, Cirincione BB, Noncompartmental Pharmacokinetics of Tigecycline in Patients with Complicated Skin and Skin Structure Infections. Session #4, Control #2634, Presentation #A-11."},{"key":"10.1016\/j.medmal.2005.02.001_bib17","unstructured":"Sun HK, Ong CT, Umer A, Harper D, Roy ST, Nightingale CH et al. Pharmacokinetic Profile of Tigecycline in Serum and Blister Fluid after Multiple Intravenous Administrations in Healthy Adults Session #4, Control #842, Presentation #A-12."},{"key":"10.1016\/j.medmal.2005.02.001_bib18","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1128\/AAC.49.1.220-229.2005","volume":"49","author":"Muralidharan","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2005.02.001_bib19","unstructured":"Zimmerman JJ, Harper D, Matschke K, Speth J, Raible DG, Runcillo RJ, Pharmacokinetics and Pharmacodynamics of Tigecycline and Digoxin Coadministered to Healthy Men. Session #44, Control #1306, Presentation #A-460."}],"container-title":["M\u00e9decine et Maladies Infectieuses"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X05000193?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X05000193?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:51:35Z","timestamp":1759971095000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0399077X05000193"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["S0399077X05000193"],"URL":"https:\/\/doi.org\/10.1016\/j.medmal.2005.02.001","relation":{},"ISSN":["0399-077X"],"issn-type":[{"type":"print","value":"0399-077X"}],"subject":[],"published":{"date-parts":[[2005,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"La tig\u00e9cycline, un nouvel antibiotique \u00e0 l'\u00e9tude chez l'homme","name":"articletitle","label":"Article Title"},{"value":"M\u00e9decine et Maladies Infectieuses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medmal.2005.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}